Page 2 - Junction Pharmacy News Today

The Government is facing calls to recognise long Covid as an occupation disease - but what is the mystery condition?

The Oxford-AstraZeneca COVID-19 vaccine appears to substantially reduce transmission of the virus, UK resea...

Danica Kirka And Jill Lawless Distributors working in a pair together go door-to-door giving out home testing kits for COVID-19 from Britains Department of Health, in Woking, England, Tuesday, Feb. 2, 2021, during Englands third national lockdown since the coronavirus outbreak began. British health authorities plan to test tens of thousands of people in a handful of areas of England, including parts of Woking, in an attempt to stop a new variant of the coronavirus first identified i...

Britains health chief says a new study supports the governments strategy of delaying the second shot so more doses can be delivered to more people. Health Secretary Matt Hancocks comments came after Oxford released a study showing that a single dose of the COVID-19 vaccine developed by Oxford University and AstraZeneca provides a high level of protection for 12 weeks. The vaccine cut transmission of the virus by two-thirds and prevented severe disease. Pharmacist Bhaveen Patel administers a do...

Pills and sprays to replace Covid jabs: Vaccine tsar Kate Bingham says needles will be phased out in battle against mutating virus - and reveals she broke Dry January with glass of wine when she heard UK-made Novavax passed trials with 90% success rate Kate Bingham revealed that she was part of Novavax trial that was found to defeat Covid in 9 out of 10 cases US biotech firm announced its vaccine had successfully completed Phase Three clinical trials in UK Under a deal with the UK government, 6...

Updated Jan 28, 2021 | 18:17 IST Even marginal changes in the rate of transmissibility can have outsize impacts concerning the total number of cases and casualties. A pharmacist administers a dose of the Oxford/AstraZeneca vaccine to an individual at a coronavirus vaccination clinic held at Junction Pharmacy in Brixton, London, Thursday, Jan. 28, 2021. &nbsp | &nbspPhoto Credit:&nbspAP Key Highlights For the most part, subtle changes in a virus genetic code are unimportan...

US biotech firm Novavax announced its vaccine had successfully completed Phase Three clinical trials in UK Under a deal with the UK government, 60million doses of the vaccine will be produced on Teesside for UK use The vaccine still requires final approval from the UKs Medicines and Healthcare products Regulatory Agency The firm Novavax last night said that the trials had shown its coronavirus vaccine was 89.3 per cent effective This trial is the first to be completed since the emergence of the...